Cargando…

A New Method for Optimizing Sepsis Therapy by Nivolumab and Meropenem Combination: Importance of Early Intervention and CTL Reinvigoration Rate as a Response Marker

Background: Recently, there has been a growing interest in applying immune checkpoint blockers (ICBs), so far used to treat cancer, to patients with bacterial sepsis. We aimed to develop a method for predicting the personal benefit of potential treatments for sepsis, and to apply it to therapy by me...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillis, Avi, Ben Yaacov, Anat, Agur, Zvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959825/
https://www.ncbi.nlm.nih.gov/pubmed/33732241
http://dx.doi.org/10.3389/fimmu.2021.616881

Ejemplares similares